1. Moderator's view: Treatment of IgA nephropathy—getting comfortable with uncertainty
   Richard J. Glassock, 2016, Nephrology Dialysis Transplantation CrossRef
2. Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial
   Zhaohui Ni et al, 2021, Renal Failure CrossRef
3. Efficacy and safety of Abelmoschus manihot for IgA nephropathy: A multicenter randomized clinical trial
   Ping Li et al, 2020, Phytomedicine CrossRef
4. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy
   Lulin Min et al, 2017, Oncotarget CrossRef
5. Efficacy and safety of leflunomide in IgA nephropathy: a systematic review and meta-analysis
   Jianwei Yi et al, 2019, International Urology and Nephrology CrossRef
6. Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study
   Sun Ying et al, 2020, Therapeutic Advances in Musculoskeletal Disease CrossRef
7. Efficacy and safety of leflunomide treatment in Takayasu arteritis: Case series from the East China cohort
   Xiaomeng Cui et al, 2020, Seminars in Arthritis and Rheumatism CrossRef
8. A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study
   Shasha Chen et al, 2018, Scientific Reports CrossRef
9. Comparison of the efficacy and safety of leflunomide versus placebo combined with basic prednisone therapy in patients with active disease phase of Takayasu arteritis: study protocol for a randomized, double-blinded controlled trial (Takayasu arteritis clinical trial in China: TACTIC)
   Ying Sun et al, 2023, Therapeutic Advances in Chronic Disease CrossRef
10. The efficacy and safety of immunosuppressive therapies in the treatment of IgA nephropathy: A network meta-analysis
    Jiaxing Tan et al, 2020, Scientific Reports CrossRef
11. Investigation of expression and influence of CTGF and HO-1 in rats with diabetic retinopathy
    Yongjian Huang et al, 2019, Experimental and Therapeutic Medicine CrossRef
12. The analysis of treatment of Immunoglobulin A-nephropathy
    Vladimir A. Dobronravov et al, 2020, Terapevticheskii arkhiv CrossRef
13. Drugs That Act on the Immune System: Immunosuppressive and Immunostimulatory Drugs
    Calvin J. Meaney et al, 2017, A Worldwide Yearly Survey of New Data in Adverse Drug Reactions CrossRef